Dobutamin Hameln 12,5 mg/ml koncentrat za otopinu za infuziju
Name | Dobutamin Hameln 12,5 mg/ml koncentrat za otopinu za infuziju |
---|---|
Former Name | Dobutamin Pharma Roth 12,5 mg/ml koncentrat za otopinu za infuziju |
Marketing Authorisation Number | HR-H-557458919 |
Active Substance | dobutaminklorid |
Composition | 1 ml koncentrata za otopinu za infuziju sadrži 12,5 mg dobutamina |
Pharmaceutical Form | koncentrat za otopinu za infuziju |
Manufacturer | Siegfried Hameln GmbH, Hameln, Njemačka hameln rds s.r.o., Modra, Slovačka |
Marketing Authorisation Holder | hameln pharma gmbh, Inselstrasse 1, Hameln, Njemačka |
Marketing Authorisation Date | 12.01.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/148 |
Registration Number | 381-12-01/30-21-02 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ograničeni recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | C01CA07 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Public Assessment Report | download |